Aclarion gets first payer coverage for Nociscan from AXA in Greater London

Aclarion, Inc.

AXA is the 2nd largest private medical insurer in the UK with ~30% market share and ~3M insured customers.
This is the first insurance company to approve payment for Nociscan; CEO calls it the most significant milestone to date.
Coverage applies to Greater London in conjunction with The London Clinic; self-pay/private insurance represents ~70% of UK private hospital revenues.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.